REDW — Redwood Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK25.16m
- SEK24.34m
Refile: BRIEF-Redwood Pharma Q1 Operating Loss At SEK 1,969 thousand
Brief: Redwood Pharma Receives Approval From The Austrian Drug Authority To Start Rp501 Clinical Trial
Brief: Redwood Pharma Q4 Operating Loss Narrows To SEK 3.6 Mln
Brief: Redwood Pharma Q3 Operating Loss Widens To SEK 6.0 Mln
Brief: Redwood Pharma Q2 Operating Loss Widens To SEK 7.0 Million
Brief: Redwood Pharma AB - Q4 Operating Loss Sek 4.3 Million
Brief: Redwood Pharma To Raise Around SEK 34.2 Mln In Rights Issue
Brief: Redwood Pharma TO Receive Approximately Sek 34.2 Million Through A Heavily Oversubscribed Rights Issue
Brief: Redwood Pharma: Intention To Move To Nasdaq First North Growth Market Stock Exchange
Brief: Redwood Pharma: Supplementary Analyses To Topline Phase II Results Reveal Additional RP101 Clinical Strengths
Brief: Redwood Pharma Carries Out Rights Issue Of About SEK 34.2 Mln
Brief: Redwood Pharma Q3 Operating Loss Narrows To SEK 2.2 Million
Brief: Redwood Pharma: Launch Of New Program To Develop Treatments Based On IntelliGel
Brief: Redwood Pharma Q2 Operating Loss Narrows To SEK 3.6 Mln
Brief: Redwood Pharma: New Patent To Be Issued In U.S.
Brief: Redwood Pharma Takes Out A Bridge Loan Of SEK 4.5 Mln
Brief: Redwood Pharma Will Receive Approximately SEK 2.1 Million
Brief: Redwood Pharma Q1 Net Loss At SEK 4.4 Million
Brief: Redwood Pharma Q4 Operating Loss Widens SEK 3.8 Million